» Articles » PMID: 27523394

Role of AhR in Positive Regulation of Cell Proliferation and Survival

Overview
Journal Cell Prolif
Date 2016 Aug 16
PMID 27523394
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The aryl hydrocarbon receptor (AhR) is an important nuclear transcription factor that is best known for mediating toxic responses by adjusting numbers of metabolism-related enzymes, including CYP1A1 and CYP1B1. Previous findings have revealed that, in addition to negatively regulating cell proliferation and survival, AhR may also positively regulate these pathways. Here, we review these findings and summarize distinct mechanisms by which AhR promotes cell proliferation and survival, including modulation of receptor expression, growth factor signalling and apoptosis, regulating the cell cycle and promoting cytokine expression. This review will aid better understanding the role of AhR in positive regulation of cell proliferation and survival.

Citing Articles

The AhR pathway regulation in phthalates-induced cancer promotion, progression and metastasis: a scoping review.

Akbariani M, Omidi M, Shahabi Z, Haghi-Aminjan H, Shadboorestan A Cancer Cell Int. 2025; 25(1):27.

PMID: 39875988 PMC: 11773746. DOI: 10.1186/s12935-024-03622-9.


Modulation of TCR stimulation and pifithrin-α improve the genomic safety profile of CRISPR-engineered human T cells.

Ursch L, Muschen J, Ritter J, Klermund J, Bernard B, Kolb S Cell Rep Med. 2024; 5(12):101846.

PMID: 39637860 PMC: 11722128. DOI: 10.1016/j.xcrm.2024.101846.


The Aryl Hydrocarbon Receptor and Its Crosstalk: A Chemopreventive Target of Naturally Occurring and Modified Phytochemicals.

Szaefer H, Licznerska B, Baer-Dubowska W Molecules. 2024; 29(18).

PMID: 39339278 PMC: 11433792. DOI: 10.3390/molecules29184283.


Aryl hydrocarbon receptor dynamics in esophageal squamous cell carcinoma: From immune modulation to therapeutic opportunities.

Rahmati M, Moghtaderi H, Mohammadi S, Al-Harrasi A World J Exp Med. 2024; 14(3):96269.

PMID: 39312702 PMC: 11372732. DOI: 10.5493/wjem.v14.i3.96269.


Advances in ex vivo expansion of hematopoietic stem and progenitor cells for clinical applications.

Branco A, Rayabaram J, Miranda C, Fernandes-Platzgummer A, Fernandes T, Sajja S Front Bioeng Biotechnol. 2024; 12:1380950.

PMID: 38846805 PMC: 11153805. DOI: 10.3389/fbioe.2024.1380950.


References
1.
Qiu J, Zhou L . Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation. Semin Immunopathol. 2013; 35(6):657-70. PMC: 3797199. DOI: 10.1007/s00281-013-0393-5. View

2.
Vonarbourg C, Mortha A, Bui V, Hernandez P, Kiss E, Hoyler T . Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. Immunity. 2010; 33(5):736-51. PMC: 3042726. DOI: 10.1016/j.immuni.2010.10.017. View

3.
Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan A . IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest. 2008; 118(2):534-44. PMC: 2157567. DOI: 10.1172/JCI33194. View

4.
Lahoti T, Hughes J, Kusnadi A, John K, Zhu B, Murray I . Aryl hydrocarbon receptor antagonism attenuates growth factor expression, proliferation, and migration in fibroblast-like synoviocytes from patients with rheumatoid arthritis. J Pharmacol Exp Ther. 2013; 348(2):236-45. PMC: 3912548. DOI: 10.1124/jpet.113.209726. View

5.
Satoh-Takayama N, Lesjean-Pottier S, Vieira P, Sawa S, Eberl G, Vosshenrich C . IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors. J Exp Med. 2010; 207(2):273-80. PMC: 2822619. DOI: 10.1084/jem.20092029. View